News: Novelos Therapeutics Inc (NVLT.PK)
NVLT.PK on OTC Markets Group
0.44USD
20 May 2013
0.44USD
20 May 2013
Price Change (% chg)
$-0.01 (-2.22%)
$-0.01 (-2.22%)
Prev Close
$0.45
$0.45
Open
$0.44
$0.44
Day's High
$0.44
$0.44
Day's Low
$0.44
$0.44
Volume
11,740
11,740
Avg. Vol
30,724
30,724
52-wk High
$2.01
$2.01
52-wk Low
$0.35
$0.35
Select another date:
Select another date:
Press Releases
- Novelos Therapeutics Closes $5.5 Million Public Offering
- Novelos Therapeutics Prices $5.5 Million Public Offering
- Novelos Therapeutics To Present At The 15th Annual BIO CEO & Investor Conference On February 11
- Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
- Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29
- Novelos Therapeutics Closes $2 Million Private Placement
- Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
- Novelos Therapeutics and Academic Collaborators Present Diapeutic Technology Platform at Imaging in 2020 Conference
- Novelos Therapeutics to Present at 11th Annual Bio Investor Forum on October 10
- Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
